pyrazines has been researched along with HTLV-I Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harding, JC; Hess, JL; Mitra-Kaushik, S; Ratner, L | 1 |
| Koya, Y; Matsuoka, M; Nosaka, K; Satou, Y; Toyokuni, S; Yasunaga, JI | 1 |
| Dirksen, WP; Fernandez, SA; Lairmore, MD; Nadella, MV; Rosol, TJ; Shu, ST; Thudi, NK; Werbeck, JL | 1 |
3 other study(ies) available for pyrazines and HTLV-I Infections
| Article | Year |
|---|---|
Effects of the proteasome inhibitor PS-341 on tumor growth in HTLV-1 Tax transgenic mice and Tax tumor transplants.
Topics: Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Division; Crosses, Genetic; Cysteine Endopeptidases; DNA Replication; Genes, pX; HTLV-I Infections; Humans; Interleukin-10; Interleukin-6; Leukemia, T-Cell; Mice; Mice, Inbred C57BL; Mice, Transgenic; Multienzyme Complexes; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines | 2004 |
Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro.
Topics: Animals; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Cell Division; Cell Line, Transformed; Cell Line, Tumor; Cysteine Endopeptidases; HTLV-I Infections; Humans; Leukemia-Lymphoma, Adult T-Cell; Mice; Mice, SCID; Multienzyme Complexes; Neoplasm Transplantation; NF-kappa B; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines; Transplantation, Heterologous | 2004 |
A novel bioluminescent mouse model and effective therapy for adult T-cell leukemia/lymphoma.
Topics: Animals; Apoptosis; Boronic Acids; Bortezomib; Cell Survival; Disease Models, Animal; Genes, Reporter; HTLV-I Infections; Humans; Jurkat Cells; Luciferases; Male; Mice; Mice, Inbred NOD; Mice, SCID; Protease Inhibitors; Pyrazines | 2007 |